Sb. Patten et al., A CASE-CONTROL STUDY OF CORTICOSTEROID EXPOSURE AS A RISK FACTOR FOR CLINICALLY-DIAGNOSED DEPRESSIVE-DISORDERS IN A HOSPITALIZED POPULATION, Canadian journal of psychiatry, 40(7), 1995, pp. 396-400
Objective: Depressive symptoms may be a side effect of exogenous corti
costeroids. However, the literature does not confirm that corticostero
id exposure is associated with the occurrence of depressive disorders.
The objective of this study was to determine whether or not corticost
eroid exposures are associated with clinical diagnoses of depressive d
isorders in hospitalized patients. Method: The study used a case-contr
ol design. Cases and 2 control groups were selected from a health reco
rds case summary database maintained at the Calgary General Hospital.
Additional data were collected by chart review. Results: The analysis
reproduced associations between depressive diagnoses and several psych
osocial and biological risk factors. However the data did not suggest
that corticosteroids were associated with an elevated risk of depressi
ve diagnoses. In fact, odds ratios for corticosteroid exposure were le
ss than 1, consistent with a protective effect Conclusions: Although c
orticosteroids may produce depressive symptoms as a side effect, corti
costeroid exposures are not associated with an elevated risk of clinic
ally diagnosed depressive disorders in hospitalized patients. There ar
e several possible explanations for this Depressive syndromes associat
ed with corticosteroid exposure may not clinically resemble depressive
disorders, and may not warrant a diagnosis of a depressive disorder.
Alternatively, clinicians may not identify, and formally diagnose depr
essive disorders caused by corticosteroids.